ProKidney grants supplemental stock option to Chief Legal Officer Todd Girolamo

PROKIDNEY CORP.

Option for 234,742 Class A ordinary shares at FMV on March 1, 2024 grant date.
Vesting: 50% on March 1, 2025; remainder in equal monthly installments over 12 months.
Award approved Feb 6, 2024 under 2022 Incentive Equity Plan for retention purposes.

item 5.02

PROKIDNEY CORP. filing history →

Source: SEC EDGAR

accession 0000950170-24-013823

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.